High levels of cyclin E1 were found in hormone receptor positive breast cancer cell lines with acquired resistance to palbociclib [117,118] and the cyclin E1/Rb ratio was proposed as a marker for palbociclib resistance [118]. The gene discussed is NR4A1; the disease is breast carcinoma.